Procedure guideline for gallium scintigraphy in the evaluation of malignant disease

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 990-994

  Bartold, Stephen P ^b   Donohoe, Kevin J ^b   Fletcher, James W ^b   Haynie, Thomas P ^b   Henkin, Robert E ^b   Silberstein, Edward B ^b   Royal, Henry D ^b   Van Den Abbeele, Annick ^b   Wong, Olivia ^a  

^a Society of Nuclear Medicine   (United States)

^b NONE

Author keywords

Gallium 67; Malignant disease; Practice guidelines

Indexed keywords

GALLIUM 67;

IMAGE ANALYSIS; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVATE PRACTICE; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; CHILD, PRESCHOOL; GALLIUM RADIOISOTOPES; HUMANS; LYMPHOMA; NEOPLASMS; RADIATION DOSAGE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030905205     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Bekerman C, Hoffer PB, Bitran JD. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 1984;14:296-323.
2. McLaughlin AF, Magee MA, Greenough R, et al. Current role of gallium scanning in the management of lymphoma. Eur J Nucl Med 1990;16:755-771.
3. McLaughlin AF, Southee AE. Gallium scintigraphy in tumor diagnosis and management. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment. New York: Churchill Livingstone; 1994:711-735.
4. Front D, Bar-Shalom R, Epelbaum R, et al. Early detection of lymphoma recurrence with gallium-67 scintigraphy. J Nucl Med 1993;34:2101-2104.
5. 67Ga scintigraphy in evaluating the results of therapy of lymphoma patients. Semin Nucl Med 1995;25:60-71.
6. King SC, Reiman RJ, Prosnitz LR. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease. J Clin Oncol 1994;12:306-311.
7. 67Ga scintigraphy after treatment. Radiology 1992;182:359-363.
8. Anderson K, Leonard R, Cannelles G, et al. High-dose gallium imaging in lymphoma. Am J Med 1983;75:327-331.
9. Cooper DL, Caride VJ, Zloty M, et al. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy. J Clin Oncol 1993;11:1092-1098.
10. Gasparini MD, Balzarini L, Castellani MR, et al. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin's lymphoma. Cancer 1993;72:577-82.
11. Karimjee S, Brada M, Husband J, et al. A comparison of gallium-67 single-photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease. Eur J Cancer 1992;11:1856-1857.
12. Kostakoglu L, Yeh SD, Portlock C, et al. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med 1992;33:345-350.
13. Kaplan WD, Jochelson MS, Herman TS, et al. Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 1990;8:1966-1970.
14. Sandrock D, Lastoria S, Magrath IT, et al. The role of gallium-67 tumor scintigraphy in patients with small, non-cleaved cell lymphoma. Eur J Nucl Med 1993;20:119-122.
15. 67Ga-citrate. Radiology 1974;110:151-154.
16. Dambro TJ, Slavin JR, James D, et al. Loss of radiogallium from lymphoma after initiation of chemotherapy. Clin Nucl Med 1992;17:32-33.
17. Fletcher JW, Herbig FK, Donati RM, et al. Gallium-67-citrate distribution following whole-body irradiation or chemotherapy. Radiology 1975;117:709-712.
18. Sephton R, Martin JJ. Modification of distribution of gallium-67 in man by administration of iron. Br J Radiol 1980;53:572-575.
19. Hattner RS, White DL. Gallium-67/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of gallium-67. J Nucl Med 1990;31:1844-1846.
20. Laven DL, Shaw SM. Detection of drug interactions involving radiopharmaceuticals: a professional responsibility of the clinical pharmacist. J Pharm Prac 1989;2:287-298.
21. Larar GN, Janicek MJ, Kaplan WD. Gallium-67 scintigraphy after bone marrow harvest. Significance of "sacroiliac" asymmetry in the lymphoma patient. Clin Nucl Med 1993;18:126-129.
22. Thomas SR, Gelfand MJ, et al. Radiation absorbed-dose estimates for the liver, spleen and metaphyseal growth complexes in children undergoing gallium-67-citrate scanning. Radiology 1983;146:817-820.
23. Feremans W, Bujan W, Neve P, et al. CD71 phenotype and the value of gallium imaging in lymphomas. Am J Hematol 1991;36:215-216.
24. Tsuchiya Y, Nakao A, Komatsu T, et al. Relationship between gallium-67-citrate scanning and transferrin receptor expression in lung diseases. Chest 1992;102:530-534.
25. Kwan AJ, Zimmerman RE, Keech FK, et al. Gallium-67 image contrast: relationship to energy peak and window width selection. Clin Nucl Med 1995;20:860.
26. Front D, Israel O, Epelbaum R, et al. Gallium-67 SPECT before and after treatment of lymphoma. Radiology 1990;175:515-519.
27. Harwood SJ, Carroll RG, Anderson M, et al. SPECT gallium scanning for lymphoma and infection. Clin Nucl Med 1987;12:694-702.
28. Rossleigh MA, Murray IP, Mackey DW, et al. Pediatric solid tumors: evaluation by gallium-67 SPECT studies. J Nucl Med 1990;31:168-172.
29. 67Ga SPECT. Radiology 1987; 164:111-114.
30. Bar-Shalom R, Ben-Arie Y, Gaitini D, et al. Gallium-67 uptake in a mass of benign transformation mimicking recurrence of nodular lymphocytic predominance Hodgkin's disease. J Nucl Med 1994;35:465-468.
31. Champion PE, Groshar D, Hooper HR, et al. Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma? Nucl Med Commun 1992;13:730-737.
32. Israel O, Front D. Benign mediastinal and parahilar uptake of gallium-67 in treated lymphoma: do we have all the answers? [Editorial]. J Nucl Med 1993;34:1330-1332.
33. Peylan-Ramu N, Haddy TB, Jones E, et al. High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma. J Clin Oncol 1989;7:1800-1806.
34. Novetsky GH, Turner DA, Ali A, et al. Cleansing the colon in gallium-67 scintigraphy: a prospective comparison of regimens. AJR 1981;137:979-981.
35. Silberstein EB, Fernando-Ulloa M, Hall J. Are oral cathartics of value in optimizing the gallium scan? J Nucl Med 1981;22:424-427.
36. Zeman RK, Ryerson TW. The value of bowel preparation in Ga-67-citrate scanning. J Nucl Med 1977;18:886-889.